Fractional Commercial Leadership
VP-level partnership and go-to-market support for leadership teams that need experienced commercial bandwidth without immediately adding a full-time executive.
Fractional commercialization for neurotech
Neurotech Strategy & Partnerships
Senior fractional commercialization and partnership support for EEG, BCI, biomarker, and human-performance companies translating credible science into scalable traction.
15+ years across neurotechnology, digital health, OEM partnerships, and commercial scaling.
Sonde HealthSavonixCereScanSKILLCOURTVielight*
Neurotechnology · Digital health · OEM integrations · Strategic alliances · Commercial scaling
* Independent, non-exclusive introducer relationship.
About Garrett Bussiere
Scientific credibility. Commercial execution.
I am a partnerships and commercialization executive with more than 15 years of experience helping neurotechnology and digital-health platforms move from promising science toward meaningful commercial traction.
My background spans OEM integrations, strategic alliances, enterprise healthcare, market development, and founder-facing commercialization strategy. I previously served as VP of Strategic Partnerships at Sonde Health, led partnerships and go-to-market initiatives at Savonix, held a commercialization role at CereScan, and currently serve as Regional Head of Partnerships & Innovation at SKILLCOURT.
I also co-authored a peer-reviewed publication on photobiomodulation for chronic traumatic brain injury and serve on the Neural Injury Center’s external advisory board.
Best fit
Built for science-driven companies at a commercial inflection point.
This work is best suited for founders and leadership teams with credible technology, a real commercial opportunity, and limited senior bandwidth to translate that opportunity into a focused market strategy and a disciplined partnership motion.
EEG
BCI
Biomarkers
Neurodiagnostics
Neuromodulation-adjacent
Human performance
Sharpen the initial market wedge.
Prioritize the right strategic partners.
Convert promising conversations into repeatable commercial traction.
How I help
Senior commercial support without the full-time executive overhead.
The work is intentionally focused: establish the commercial wedge, identify the right partners, and build a repeatable path from credible technology to revenue traction.
Strategic Partnerships & OEM Integrations
Partner mapping, outreach strategy, deal structuring, licensing, distribution, and commercial alliances designed around the strongest path to scale.
GTM, Pilots & Scale
Market prioritization, pilot design, strategic-account development, and repeatable commercialization playbooks that move beyond one-off conversations.
What an engagement produces
Concrete outputs. Not advisory theater.
Each engagement is scoped around the company’s stage, technology, and highest-leverage commercial objective. Typical deliverables include:
✓
Commercial wedge and priority-market definition
✓
Partnership opportunity map and target-account pipeline
✓
Founder-facing positioning and outreach narrative
✓
Pilot, OEM, licensing, or distribution strategy
✓
Support for high-value partner conversations
✓
Repeatable pilot-to-scale commercialization playbook
Relevant experience
A career built at the intersection of neuroscience and commercialization.
The work draws on operating experience across emerging neurotechnology, digital health, enterprise healthcare, performance technology, and current independent commercial relationships.
Sonde Health
VP of Strategic Partnerships
Strategic partnerships and new distribution channels for vocal-biomarker technology, including OEM-oriented commercial pathways.
Savonix
Partnerships & GTM Leadership
Enterprise healthcare commercialization, strategic partnerships, and go-to-market development for digital cognitive assessment.
CereScan
Commercialization Experience
Commercial market development within neuroimaging and brain-health services.
SKILLCOURT
Regional Head of Partnerships & Innovation
Partnership development and go-to-market strategy for a neurocognitive motor-training platform used across performance and rehabilitation settings.
Vielight
Independent, Non-Exclusive Introducer
Independent channel-development and commercial-introduction relationship for photobiomodulation products. Growth Factor Method is not an employee, agent, legal representative, or branch of Vielight.
Engagement model
Focused support. Clear priorities. Measurable progress.
The default model is a fractional commercialization and strategic-partnership engagement. Focused sprints are also available when the strategic objective is narrow and clearly defined.
01
Discovery
A direct conversation about the technology, the commercial constraints, and the highest-leverage opportunities.
02
Scope
A tailored engagement plan with clear priorities, deliverables, operating cadence, and decision points.
03
Execution
Embedded support for partner strategy, pipeline development, strategic conversations, and commercial decision-making.
Start the conversation
Let’s talk about your commercial next step.
I work with a small number of science-driven neurotechnology and human-performance companies at a time. If the technology is credible and the commercial pathway needs sharper definition, let’s discuss whether there is a fit.
Discuss a Fractional Engagement